نتائج البحث - Gustaaf W. van Imhoff

تنقيح النتائج
  1. 1
    Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma

    Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphoma حسب Bart Schot, Josée M. Zijlstra, Wim J. Sluiter, Gustaaf W. van Imhoff, Jan Pruim, Willem Vaalburg, Edo Vellenga

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of <scp>sG</scp>alectin‐1, <scp>sCD</scp>163 and <scp>sCD</scp>30 with TARC

    Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of <scp>sG</scp>alectin‐1, <scp>sCD</scp>163 and <scp>sCD</scp>30 with TARC حسب Wouter J. Plattel, Zainab N. D. Alsada, Gustaaf W. van Imhoff, Arjan Diepstra, Anke van den Berg, Lydia Visser

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Anti-GM1 antibodies in patients with Guillain-Barre syndrome.

    Anti-GM1 antibodies in patients with Guillain-Barre syndrome. حسب Leonard H. van den Berg, J. Marrink, Agnes Jager, Herman de Jong, Gustaaf W. van Imhoff, Norman Latov, Saud Sadiq

    منشور في 1992
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients

    Latent Epstein-Barr Virus Infection of Tumor Cells in Classical Hodgkin's Lymphoma Predicts Adverse Outcome in Older Adult Patients حسب Arjan Diepstra, Gustaaf W. van Imhoff, Michael Schaapveld, Henrike E. Karim‐Kos, Anke van den Berg, Edo Vellenga, Sibrand Poppema

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Double-hit B-cell lymphomas

    Double-hit B-cell lymphomas حسب Sietse Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W. van Imhoff, Hanneke C. Kluin‐Nelemans, Evert-Jan G. Boerma, Philip M. Kluin

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?

    HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy? حسب Marcel Nijland, Rianne Veenstra, Lydia Visser, Chuanhui Xu, Kushi Kushekhar, Gustaaf W. van Imhoff, Philip M. Kluin, Anke van den Berg, Arjan Diepstra

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma

    Prognostic Impact of Germinal Center–Associated Proteins and Chromosomal Breakpoints in Poor-Risk Diffuse Large B-Cell Lymphoma حسب Gustaaf W. van Imhoff, Evert-Jan G. Boerma, Bronno van der Holt, Ed Schuuring, Leo F. Verdonck, Hanneke C. Kluin‐Nelemans, Philip M. Kluin

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma

    Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma حسب Hanneke C. Kluin‐Nelemans, Marinus van Marwijk Kooy, Pieternella J. Lugtenburg, Wim L.J. van Putten, Marleen Luten, Joost J. Oudejans, Gustaaf W. van Imhoff

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE WITH RITUXIMAB

    TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE WITH RITUXIMAB حسب Erik A.M. Verschuuren, Servi J.C. Stevens, Gustaaf W. van Imhoff, Jaap M. Middeldorp, Conny de Boer, Gerard H. Koëter, Hauw The, Wim van der Bij

    منشور في 2002
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study

    Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study حسب Rodney Pollard, Justin Pijpe, Hendrika Bootsma, Fred K. L. Spijkervet, Philip M. Kluin, Jan L.N. Roodenburg, Cees G. M. Kallenberg, Arjan Vissink, Gustaaf W. van Imhoff

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma

    Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma حسب Wouter J. Plattel, Anke van den Berg, Leo H. Visser, Anne Marijn van der Graaf, Jan Pruim, Hans Vos, Bouke G. Hepkema, Arjan Diepstra, Gustaaf W. van Imhoff

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma

    HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma حسب Arjan Diepstra, Gustaaf W. van Imhoff, Henrike E. Karim‐Kos, Anke van den Berg, Gerard J. te Meerman, Marijke Niens, Ilja M. Nolte, Esther Bastiaannet, Michael Schaapveld, Edo Vellenga, Sibrand Poppema

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive

    Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive حسب Anneke Bosga-Bouwer, Gustaaf W. van Imhoff, Ronald Boonstra, Anneke van Veen, Eugenia Haralambieva, Anke van den Berg, Bauke M. de Jong, Vanessa Krause, Martin Palmer, Robert Coupland, Philip M. Kluin, Eva van den Berg, Sibrand Poppema

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry

    High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Bloo... حسب Nicolas Mounier, Carmen Canals, Christian Gisselbrecht, Jan J. Cornelissen, Roberto Foá, Eulogio Conde, J Maertens, Michel Attal, Alessandro Rambaldi, Charles Crawley, J.J. Luan, Mats Brune, Sébastian Wittnebel, Gordon Cook, Gustaaf W. van Imhoff, Michael Pfreundschuh, Anna Sureda

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial

    Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial حسب Edo Vellenga, Wim L.J. van Putten, Mars B. van ’t Veer, Josée M. Zijlstra, Willem E. Fibbe, Marinus H. J. van Oers, Leo F. Verdonck, Pierre W. Wijermans, Gustaaf W. van Imhoff, Pieternella J. Lugtenburg, Peter C. Huijgens

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

    European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma حسب Pier Luigi Zinzani, Lionel Karlin, John Radford, Dolores Caballero, Paul Fields, Martine E.D. Chamuleau, Francesco d’Amore, Corinne Haïoun, Catherine Thiéblemont, Eva González‐Barca, Coralith García, Peter Johnson, Gustaaf W. van Imhoff, Tony Ng, Karen M. Dwyer, F. Morschhauser

    منشور في 2016
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma

    Comparison of CHOP Chemotherapy with Autologous Bone Marrow Transplantation for Slowly Responding Patients with Aggressive Non-Hodgkin's Lymphoma حسب Leo F. Verdonck, Wim L.J. van Putten, Anton Hagenbeek, Harry C. Schouten, Pieter Sonneveld, Gustaaf W. van Imhoff, Hanneke C. Kluin‐Nelemans, John Raemaekers, Rien H. J. Van Oers, Hans L. Haak, Rik Schots, A. W. Dekker, Gijsbert C. de Gast, Bob Löwenberg

    منشور في 1995
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Should the standard dimethyl sulfoxide concentration be reduced? Results of a <scp>E</scp>uropean <scp>G</scp>roup for <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide

    Should the standard dimethyl sulfoxide concentration be reduced? Results of a <scp>E</scp>uropean <scp>G</scp>roup for <scp>B</scp>lood and <scp>M</scp>arrow <scp>T</scp>ransplanta... حسب Curly Morris, Liesbeth C. de Wreede, Marijke Scholten, Ronald Brand, Anja van Biezen, Anna Sureda, Ebbe Dickmeiss, Marek Trněný, Jane F. Apperley, Patrizia Chiusolo, Gustaaf W. van Imhoff, Stig Lenhoff, Giovanni Martinelli, Marcus Hentrich, Thomas Pabst, Francesco Onida, Michael Quinn, Nicolaus Kröger, Théo de Witte, Tapani Ruutu

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens

    Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens حسب Liesbeth E.M. Oosten, Martine E.D. Chamuleau, Frederick W. Thielen, L. C. de Wreede, Claire Siemes, Jeanette K. Doorduijn, Oscar S. Smeekes, Marie José Kersten, Lizan Hardi, Joke W. Baars, A. M. P. Demandt, Wendy B.C. Stevens, Marcel Nijland, Gustaaf W. van Imhoff, Rolf E. Brouwer, Carin A. Uyl‐de Groot, P. M. Kluin, Daphne de Jong, Hendrik Veelken

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

    Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma حسب Michael Schaapveld, Berthe M.P. Aleman, Anna M. van Eggermond, Cécile P.M. Janus, Augustinus D. G. Krol, Richard W.M. van der Maazen, Judith M. Roesink, John Raemaekers, Jan Paul de Boer, Josée M. Zijlstra, Gustaaf W. van Imhoff, Eefke Petersen, Philip Poortmans, Max Beijert, Marnix L.M. Lybeert, Ina Mulder, Otto Visser, Marieke W.J. Louwman, Inge M. Krul, Pieternella J. Lugtenburg, Flora E. van Leeuwen

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: